Cargando…

H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro

BACKGROUND: Several risk factors contribute to the inflammation promoting hepatocellular carcinoma (HCC) development, but the underlying mechanisms are unknown. Human endogenous retrovirus H long terminal repeat-associating 2 (HHLA2), a B7 family member, is highly expressed in various malignant tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Min, Xiong, Yao, Lin, Yan, Liang, Rong, Li, Yongqiang, Ge, Lianying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Database Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132585/ https://www.ncbi.nlm.nih.gov/pubmed/33990536 http://dx.doi.org/10.12659/MSM.930215

Ejemplares similares

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
por: Luo, Min, et al.
Publicado: (2021)

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020)

Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma
por: Zhao, Xuemiao, et al.
Publicado: (2021)

H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation
por: Li, Zongkuo, et al.
Publicado: (2022)

The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis
por: Shimonosono, Masataka, et al.
Publicado: (2018)

Fibrinogen-Like Protein 2 (FGL2) is a Novel Biomarker for Clinical Prediction of Human Breast Cancer
por: Feng, Yanyan, et al.
Publicado: (2020)

Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma
por: Ding, Lin, et al.
Publicado: (2022)

Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma
por: Wang, Lan-Lan, et al.
Publicado: (2021)

Retrospective Study from a Single Center to Identify Risk Factors Associated with Reinfection in Patients Undergoing 2-Stage Revision Surgery for Periprosthetic Joint Infection
por: Zhang, Bingshi, et al.
Publicado: (2022)

An Individualized Immune Prognostic Index is a Superior Predictor of Survival of Hepatocellular Carcinoma
por: Wang, Xiaodong, et al.
Publicado: (2020)

HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
por: Xu, Yituo, et al.
Publicado: (2021)

Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Tian, Zongbiao, et al.
Publicado: (2020)

NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma
por: Li, Zigang, et al.
Publicado: (2023)

KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
por: Li, Yang, et al.
Publicado: (2022)

Early Death Incidence and Prediction in Stage IV Breast Cancer
por: Zhao, Yumei, et al.
Publicado: (2020)

Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma
por: Liu, Zhikun, et al.
Publicado: (2021)

Identification of Fibrotic Biomarkers Associated with Macrophages in Diabetic Nephropathy
por: Hou, Rongrong, et al.
Publicado: (2023)

A Predictive Nomogram for Early Mortality in Stage IV Gastric Cancer
por: Feng, Yuqian, et al.
Publicado: (2020)

A Population-Based Analysis of Distant Metastasis in Stage IV Gastric Cancer
por: Zhang, Yiran, et al.
Publicado: (2020)

Integrated Bioinformatics Analysis Reveals Potential Pathway Biomarkers and Their Interactions for Clubfoot
por: Ding, Jing, et al.
Publicado: (2020)

Identification of Biomarkers for Sarcoidosis and Tuberculosis of the Lung Using Systematic and Integrated Analysis
por: Zhao, Min, et al.
Publicado: (2020)

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance
por: Zhao, Hua, et al.
Publicado: (2021)

Bioinformatics Analysis and Identification of Underlying Biomarkers Potentially Linking Allergic Rhinitis and Asthma
por: Yan, Zhanfeng, et al.
Publicado: (2020)

Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma
por: Zhang, Dehua, et al.
Publicado: (2020)

An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer
por: Yang, Zhi-Qiang, et al.
Publicado: (2020)

Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis
por: Li, Dong, et al.
Publicado: (2021)

Combining Blood-Based Biomarkers to Predict Mortality of Sepsis at Arrival at the Emergency Department
por: Xie, Yinjing, et al.
Publicado: (2021)

Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal Cancer
por: Zhang, Zhiyong, et al.
Publicado: (2021)

Screening and Identification of Potential Peripheral Blood Biomarkers for Alzheimer’s Disease Based on Bioinformatics Analysis
por: Wang, Xin, et al.
Publicado: (2020)

Bioinformatics Identification of Candidate Biomarkers in Endomyocardial Biopsy and Peripheral Blood for Cardiac Allograft Rejection
por: Luo, Kang, et al.
Publicado: (2022)

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics
por: Kou, Yan-qi, et al.
Publicado: (2023)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
Publicado: (2021)

Identification of CXCL13 as an Immune-Related Biomarker Associated with Tumorigenesis and Prognosis in Cutaneous Melanoma Patients
por: Si, Zebing, et al.
Publicado: (2021)

Impact of Post-Mastectomy Radiation Therapy for Sentinel Lymph Node Micrometastases in Early-Stage Breast Cancer Patients
por: Luo, Hua, et al.
Publicado: (2022)

Integrated Analysis of Angiogenesis-Mediated Tumor Immune Microenvironment Pattern in Hepatocellular Carcinoma (HCC) and a Novel Prognostic Model Construction to Predict Patient Outcome
por: Lv, Chengqian, et al.
Publicado: (2021)

Identification of Potential Prognostic and Predictive Biomarkers for Immune-Checkpoint Inhibitor Response in Small Cell Lung Cancer
por: Gao, Chanchan, et al.
Publicado: (2021)

Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer
por: Shan, Zexing, et al.
Publicado: (2021)

Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival
por: Farrag, Mayada Saad, et al.
Publicado: (2021)

Glutathione Peroxidase 8 as a Prognostic Biomarker of Gastric Cancer: An Analysis of The Cancer Genome Atlas (TCGA) Data
por: Zhang, Xinxin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9odqm5eulcm8d03pf5p81593dd